These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31161337)

  • 1. Diagnosis and treatment of cognitive impairment.
    von Arnim CAF; Bartsch T; Jacobs AH; Holbrook J; Bergmann P; Zieschang T; Polidori MC; Dodel R
    Z Gerontol Geriatr; 2019 Jul; 52(4):309-315. PubMed ID: 31161337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.
    Wong CW
    Drugs Aging; 2016 Jul; 33(7):451-60. PubMed ID: 27154396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug treatment of Alzheimer's dementia : Status quo and perspectives].
    Müller P; Fendt M; Müller NG
    Internist (Berl); 2019 Jul; 60(7):761-768. PubMed ID: 31139854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.
    Popp J; Arlt S
    Curr Opin Psychiatry; 2011 Nov; 24(6):556-61. PubMed ID: 21934621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of Dementia: State of the Art].
    Roeben B; Zieschang T; Maetzler W
    Dtsch Med Wochenschr; 2018 May; 143(10):741-747. PubMed ID: 29727890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of dementia.
    Schwarz S; Froelich L; Burns A
    Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
    Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do we treat people with dementia in Croatia.
    Mimica N; Presecki P
    Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatment strategies for Alzheimer's disease: is there a hope?
    Aprahamian I; Stella F; Forlenza OV
    Indian J Med Res; 2013 Oct; 138(4):449-60. PubMed ID: 24434253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antidementia Drug Therapy of Alzheimer's Dementia: Status 2018 and Outlook].
    Hausner L; Frölich L
    Dtsch Med Wochenschr; 2019 Feb; 144(3):156-160. PubMed ID: 30703832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
    Desmidt T; Hommet C; Camus V
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current approaches to the pharmacological treatment of Alzheimer's disease.
    Tan EC; Hilmer SN; Garcia-Ptacek S; Bell JS
    Aust J Gen Pract; 2018 Sep; 47(9):586-592. PubMed ID: 30244564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antidementia drugs].
    Müller-Spahn F; Sollberger D; Wollmer MA
    Ther Umsch; 2009 Jun; 66(6):432-40. PubMed ID: 19496039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of memantine for the treatment of dementia.
    Lo D; Grossberg GT
    Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in Parkinson's disease.
    Ransmayr G
    Psychiatr Danub; 2015 Dec; 27(4):458-61. PubMed ID: 26609664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of dementia].
    Blom K; van den Elsen GAH; Koek HL; Sanders JB; Kruithof HC; Claassen JAHR
    Ned Tijdschr Geneeskd; 2017; 161():D1851. PubMed ID: 28936936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and Real-Life Outcomes of Dementia and Cognitive Impairment at a Geriatric Clinic.
    Chulakadabba K; Muangpaisan W; Siritipakorn P; Wongviriyawong T; Suraarunsumrit P; Chalermsri C; Intalapaporn S; Chatthanawaree W; Srinonprasert V; Assantachai P
    Dement Geriatr Cogn Disord; 2020; 49(3):312-320. PubMed ID: 33075794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
    Schölzel-Dorenbos CJ;
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.
    Buckley JS; Salpeter SR
    Drugs Aging; 2015 Jun; 32(6):453-67. PubMed ID: 25941104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.